Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Snyder

Showing results (311-320 of 320) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 320 results.
Bioorganic & Medicinal Chemistry Letters|January 1, 2013
HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologiesOmar D Lopez, Van N Nguyen, Denis R St Laurent, et al.
American Journal of Preventive Medicine|August 23, 2014
Mass media health communication campaigns combined with health-related product distribution: a community guide systematic reviewMaren N Robinson, Kristin A Tansil, Randy W Elder, et al.
Journal of Medicinal Chemistry|April 12, 2013
HCV NS5A replication complex inhibitors. Part 4. Optimization for genotype 1a replicon inhibitory activityDenis R St Laurent, Michael H Serrano-Wu, Makonen Belema, et al.
The Journal of Biological Chemistry|December 3, 2010
Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activityJianying Dong, Arlene Sereno, William B Snyder, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5Fukang Yang, Lawrence B Snyder, Anand Balakrishnan, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2005
Biaryl isoxazolinone antibacterial agentsClaude A Quesnelle, Patrice Gill, Stephan Roy, et al.
Mabs|March 12, 2011
A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activityJianying Dong, Arlene Sereno, Dikran Aivazian, et al.
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability - Sickle Cell Data Collection Program, 11 States, 2016-2020Mariam Kayle, Audrey L Blewer, Wei Pan, et al.
Physical Review Letters|March 28, 2015
Pedestal bifurcation and resonant field penetration at the threshold of edge-localized mode suppression in the DIII-D TokamakR Nazikian, C Paz-Soldan, J D Callen, et al.
Journal of Medicinal Chemistry|February 14, 2014
Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvirMakonen Belema, Van N Nguyen, Carol Bachand, et al.
Pageof 32

Showing results (311-320 of 320) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 320 results.
Bioorganic & Medicinal Chemistry Letters|January 1, 2013
HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologiesOmar D Lopez, Van N Nguyen, Denis R St Laurent, et al.
American Journal of Preventive Medicine|August 23, 2014
Mass media health communication campaigns combined with health-related product distribution: a community guide systematic reviewMaren N Robinson, Kristin A Tansil, Randy W Elder, et al.
Journal of Medicinal Chemistry|April 12, 2013
HCV NS5A replication complex inhibitors. Part 4. Optimization for genotype 1a replicon inhibitory activityDenis R St Laurent, Michael H Serrano-Wu, Makonen Belema, et al.
The Journal of Biological Chemistry|December 3, 2010
Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activityJianying Dong, Arlene Sereno, William B Snyder, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5Fukang Yang, Lawrence B Snyder, Anand Balakrishnan, et al.
Bioorganic & Medicinal Chemistry Letters|May 5, 2005
Biaryl isoxazolinone antibacterial agentsClaude A Quesnelle, Patrice Gill, Stephan Roy, et al.
Mabs|March 12, 2011
A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activityJianying Dong, Arlene Sereno, Dikran Aivazian, et al.
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability - Sickle Cell Data Collection Program, 11 States, 2016-2020Mariam Kayle, Audrey L Blewer, Wei Pan, et al.
Physical Review Letters|March 28, 2015
Pedestal bifurcation and resonant field penetration at the threshold of edge-localized mode suppression in the DIII-D TokamakR Nazikian, C Paz-Soldan, J D Callen, et al.
Journal of Medicinal Chemistry|February 14, 2014
Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvirMakonen Belema, Van N Nguyen, Carol Bachand, et al.
Pageof 32